Share Price and Basic Stock Data
Last Updated: June 13, 2025, 8:25 pm
| PEG Ratio | 5.99 |
|---|
Competitors of Sumitomo Chemical India Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Epigral Ltd | 7,899 Cr. | 1,828 | 2,408/1,299 | 22.4 | 441 | 0.27 % | 24.9 % | 22.3 % | 10.0 |
| Dharmaj Crop Guard Ltd | 952 Cr. | 278 | 390/165 | 27.3 | 117 | 0.00 % | 12.0 % | 9.24 % | 10.0 |
| Bhaskar Agrochemicals Ltd | 56.3 Cr. | 108 | 122/50.0 | 14.4 | 34.1 | 0.00 % | 21.3 % | 24.7 % | 10.0 |
| Bhagiradha Chemicals & Industries Ltd | 3,975 Cr. | 307 | 448/243 | 145 | 53.9 | 0.03 % | 7.44 % | 4.91 % | 1.00 |
| Best Agrolife Ltd | 789 Cr. | 334 | 732/244 | 11.3 | 320 | 0.90 % | 12.9 % | 9.95 % | 10.0 |
| Industry Average | 11,707.45 Cr | 1,588.97 | 36.69 | 435.98 | 0.31% | 15.26% | 19.94% | 7.25 |
Quarterly Result
| Metric | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 664 | 986 | 1,122 | 753 | 652 | 724 | 903 | 540 | 664 | 832 | 971 | 622 | 665 |
| Expenses | 555 | 798 | 843 | 632 | 571 | 643 | 715 | 474 | 526 | 670 | 729 | 521 | 548 |
| Operating Profit | 109 | 188 | 278 | 121 | 81 | 81 | 188 | 66 | 139 | 162 | 242 | 101 | 117 |
| OPM % | 16% | 19% | 25% | 16% | 12% | 11% | 21% | 12% | 21% | 19% | 25% | 16% | 18% |
| Other Income | 7 | 5 | 11 | 13 | 17 | 18 | 25 | 27 | 27 | 26 | 31 | 31 | 31 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 11 | 11 | 15 | 11 | 14 | 14 | 16 | 16 | 16 | 14 | 15 | 18 | 16 |
| Profit before tax | 104 | 180 | 272 | 121 | 82 | 83 | 196 | 76 | 149 | 173 | 257 | 113 | 132 |
| Tax % | 28% | 23% | 26% | 25% | 12% | 26% | 27% | 27% | 26% | 26% | 26% | 25% | 25% |
| Net Profit | 75 | 138 | 202 | 91 | 72 | 62 | 144 | 55 | 109 | 128 | 191 | 84 | 98 |
| EPS in Rs | 1.50 | 2.77 | 4.05 | 1.82 | 1.45 | 1.24 | 2.88 | 1.10 | 2.19 | 2.57 | 3.82 | 1.69 | 1.97 |
Last Updated: May 31, 2025, 7:40 am
Below is a detailed analysis of the quarterly data for Sumitomo Chemical India Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Sales, as of Mar 2025, the value is 665.00 Cr.. The value appears strong and on an upward trend. It has increased from 622.00 Cr. (Dec 2024) to 665.00 Cr., marking an increase of 43.00 Cr..
- For Expenses, as of Mar 2025, the value is 548.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 521.00 Cr. (Dec 2024) to 548.00 Cr., marking an increase of 27.00 Cr..
- For Operating Profit, as of Mar 2025, the value is 117.00 Cr.. The value appears strong and on an upward trend. It has increased from 101.00 Cr. (Dec 2024) to 117.00 Cr., marking an increase of 16.00 Cr..
- For OPM %, as of Mar 2025, the value is 18.00%. The value appears strong and on an upward trend. It has increased from 16.00% (Dec 2024) to 18.00%, marking an increase of 2.00%.
- For Other Income, as of Mar 2025, the value is 31.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 31.00 Cr..
- For Interest, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 1.00 Cr..
- For Depreciation, as of Mar 2025, the value is 16.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 18.00 Cr. (Dec 2024) to 16.00 Cr., marking a decrease of 2.00 Cr..
- For Profit before tax, as of Mar 2025, the value is 132.00 Cr.. The value appears strong and on an upward trend. It has increased from 113.00 Cr. (Dec 2024) to 132.00 Cr., marking an increase of 19.00 Cr..
- For Tax %, as of Mar 2025, the value is 25.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 25.00%.
- For Net Profit, as of Mar 2025, the value is 98.00 Cr.. The value appears strong and on an upward trend. It has increased from 84.00 Cr. (Dec 2024) to 98.00 Cr., marking an increase of 14.00 Cr..
- For EPS in Rs, as of Mar 2025, the value is 1.97. The value appears strong and on an upward trend. It has increased from 1.69 (Dec 2024) to 1.97, marking an increase of 0.28.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: May 15, 2025, 5:09 am
| Metric | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 495 | 635 | 671 | 724 | 799 | 1,911 | 2,223 | 2,423 | 2,643 | 3,060 | 3,511 | 2,833 | 3,090 |
| Expenses | 484 | 587 | 614 | 635 | 698 | 1,691 | 1,932 | 2,088 | 2,155 | 2,458 | 2,843 | 2,358 | 2,446 |
| Operating Profit | 10 | 48 | 57 | 89 | 101 | 219 | 291 | 335 | 488 | 603 | 668 | 474 | 644 |
| OPM % | 2% | 8% | 8% | 12% | 13% | 11% | 13% | 14% | 18% | 20% | 19% | 17% | 21% |
| Other Income | 3 | 3 | 8 | 26 | 10 | 31 | -0 | -20 | 19 | 36 | 45 | 96 | 115 |
| Interest | -0 | 2 | 1 | 1 | 1 | 5 | 5 | 7 | 7 | 8 | 6 | 5 | 5 |
| Depreciation | -0 | 6 | 6 | 7 | 7 | 24 | 28 | 41 | 47 | 45 | 52 | 61 | 64 |
| Profit before tax | 13 | 43 | 58 | 107 | 103 | 221 | 258 | 267 | 453 | 586 | 655 | 503 | 691 |
| Tax % | -0% | 23% | 40% | 40% | 40% | 34% | 35% | 23% | 24% | 26% | 23% | 27% | |
| Net Profit | 13 | 33 | 35 | 65 | 62 | 145 | 167 | 206 | 345 | 434 | 503 | 370 | 513 |
| EPS in Rs | 4.12 | 6.92 | 8.69 | 10.09 | 7.41 | 10.27 | |||||||
| Dividend Payout % | -0% | -0% | -0% | -0% | -0% | -0% | 38% | 18% | 12% | 12% | 12% | 80% |
YoY Net Profit Growth
| Year | 2013-2014 | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 153.85% | 6.06% | 85.71% | -4.62% | 133.87% | 15.17% | 23.35% | 67.48% | 25.80% | 15.90% | -26.44% |
| Change in YoY Net Profit Growth (%) | 0.00% | -147.79% | 79.65% | -90.33% | 138.49% | -118.70% | 8.18% | 44.12% | -41.68% | -9.90% | -42.34% |
Sumitomo Chemical India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 5% |
| 3 Years: | 0% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 17% |
| 3 Years: | 5% |
| TTM: | 36% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 12% |
| 3 Years: | 4% |
| 1 Year: | 1% |
| Return on Equity | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 21% |
| 3 Years: | 19% |
| Last Year: | 19% |
Last Updated: Unknown
Balance Sheet
Last Updated: June 12, 2025, 2:39 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 233 | 233 | 233 | 275 | 275 | 275 | 499 | 499 | 499 | 499 | 499 | 499 |
| Reserves | -36 | -2 | 63 | 360 | 665 | 761 | 710 | 1,029 | 1,425 | 1,881 | 1,941 | 2,397 |
| Borrowings | 0 | 0 | 0 | 0 | 10 | 20 | 36 | 33 | 38 | 34 | 25 | 45 |
| Other Liabilities | 243 | 234 | 280 | 288 | 695 | 791 | 848 | 1,097 | 1,047 | 955 | 822 | 988 |
| Total Liabilities | 440 | 466 | 576 | 922 | 1,644 | 1,846 | 2,093 | 2,658 | 3,009 | 3,368 | 3,287 | 3,930 |
| Fixed Assets | 47 | 51 | 52 | 53 | 267 | 279 | 319 | 309 | 390 | 430 | 489 | 501 |
| CWIP | 0 | 0 | 1 | 7 | 9 | 8 | 10 | 14 | 35 | 71 | 23 | 9 |
| Investments | 0 | 0 | 0 | 277 | 2 | 1 | 87 | 291 | 357 | 239 | 425 | 601 |
| Other Assets | 393 | 415 | 523 | 585 | 1,367 | 1,558 | 1,676 | 2,043 | 2,227 | 2,628 | 2,351 | 2,819 |
| Total Assets | 440 | 466 | 576 | 922 | 1,644 | 1,846 | 2,093 | 2,658 | 3,009 | 3,368 | 3,287 | 3,930 |
Below is a detailed analysis of the balance sheet data for Sumitomo Chemical India Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 499.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 499.00 Cr..
- For Reserves, as of Mar 2025, the value is 2,397.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,941.00 Cr. (Mar 2024) to 2,397.00 Cr., marking an increase of 456.00 Cr..
- For Borrowings, as of Mar 2025, the value is 45.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 25.00 Cr. (Mar 2024) to 45.00 Cr., marking an increase of 20.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 988.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 822.00 Cr. (Mar 2024) to 988.00 Cr., marking an increase of 166.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 3,930.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,287.00 Cr. (Mar 2024) to 3,930.00 Cr., marking an increase of 643.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 501.00 Cr.. The value appears strong and on an upward trend. It has increased from 489.00 Cr. (Mar 2024) to 501.00 Cr., marking an increase of 12.00 Cr..
- For CWIP, as of Mar 2025, the value is 9.00 Cr.. The value appears to be declining and may need further review. It has decreased from 23.00 Cr. (Mar 2024) to 9.00 Cr., marking a decrease of 14.00 Cr..
- For Investments, as of Mar 2025, the value is 601.00 Cr.. The value appears strong and on an upward trend. It has increased from 425.00 Cr. (Mar 2024) to 601.00 Cr., marking an increase of 176.00 Cr..
- For Other Assets, as of Mar 2025, the value is 2,819.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,351.00 Cr. (Mar 2024) to 2,819.00 Cr., marking an increase of 468.00 Cr..
- For Total Assets, as of Mar 2025, the value is 3,930.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,287.00 Cr. (Mar 2024) to 3,930.00 Cr., marking an increase of 643.00 Cr..
Notably, the Reserves (2,397.00 Cr.) exceed the Borrowings (45.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 10.00 | 48.00 | 57.00 | 89.00 | 101.00 | 209.00 | 271.00 | 299.00 | 455.00 | 565.00 | 634.00 | 449.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 96 | 90 | 83 | 92 | 101 | 105 | 110 | 128 | 117 | 101 | 98 | 91 |
| Inventory Days | 125 | 135 | 169 | 191 | 202 | 193 | 133 | 185 | 198 | 157 | 135 | |
| Days Payable | 134 | 109 | 132 | 115 | 176 | 136 | 112 | 145 | 110 | 87 | 96 | |
| Cash Conversion Cycle | 96 | 81 | 109 | 130 | 177 | 131 | 167 | 150 | 157 | 189 | 168 | 131 |
| Working Capital Days | 62 | 58 | 69 | 79 | 113 | 115 | 119 | 111 | 97 | 128 | 138 | 175 |
| ROCE % | 8% | 25% | 27% | 41% | 22% | 29% | 27% | 26% | 33% | 34% | 30% | 21% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| 360 ONE Focused Equity Fund | 3,623,637 | 2.38 | 146.41 | 3,623,637 | 2025-04-22 17:25:20 | 0% |
| Axis Midcap Fund | 2,222,646 | 0.37 | 89.81 | 2,222,646 | 2025-04-22 17:25:20 | 0% |
| HSBC Small Cap Fund - Regular Plan | 2,106,600 | 0.64 | 85.12 | 2,106,600 | 2025-04-22 17:25:20 | 0% |
| Axis Growth Opportunities Fund | 1,859,682 | 0.7 | 75.14 | 1,859,682 | 2025-04-22 17:25:20 | 0% |
| PGIM India Midcap Opportunities Fund | 1,578,298 | 0.63 | 63.77 | 1,578,298 | 2025-04-22 17:25:20 | 0% |
| ICICI Prudential MidCap Fund | 1,063,453 | 0.84 | 42.97 | 1,063,453 | 2025-04-22 17:25:20 | 0% |
| Tata Ethical Fund - Regular Plan | 797,200 | 1.47 | 32.21 | 797,200 | 2025-04-22 17:25:20 | 0% |
| Aditya Birla Sun Life MNC Fund - Div | 647,284 | 0.73 | 26.15 | 647,284 | 2025-04-22 17:25:20 | 0% |
| Aditya Birla Sun Life MNC Fund - Gr | 647,284 | 0.73 | 26.15 | 647,284 | 2025-04-22 17:25:20 | 0% |
| ICICI Prudential Manufacturing Fund | 508,258 | 0.9 | 20.54 | 508,258 | 2025-04-22 17:25:20 | 0% |
Key Financial Ratios
| Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 7.40 | 10.06 | 8.49 | 6.92 | 4.10 |
| Diluted EPS (Rs.) | 7.40 | 10.06 | 8.49 | 6.92 | 4.10 |
| Cash EPS (Rs.) | 8.65 | 11.10 | 9.38 | 7.85 | 4.92 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 48.97 | 47.72 | 38.61 | 30.88 | 24.48 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 48.97 | 47.72 | 38.61 | 30.88 | 24.48 |
| Revenue From Operations / Share (Rs.) | 56.98 | 70.34 | 61.40 | 52.99 | 48.58 |
| PBDIT / Share (Rs.) | 11.42 | 14.25 | 12.56 | 10.13 | 6.89 |
| PBIT / Share (Rs.) | 10.18 | 13.21 | 11.66 | 9.19 | 6.07 |
| PBT / Share (Rs.) | 10.08 | 13.11 | 11.53 | 9.08 | 5.34 |
| Net Profit / Share (Rs.) | 7.41 | 10.06 | 8.48 | 6.92 | 4.10 |
| NP After MI And SOA / Share (Rs.) | 7.40 | 10.06 | 8.48 | 6.92 | 4.10 |
| PBDIT Margin (%) | 20.05 | 20.26 | 20.45 | 19.10 | 14.18 |
| PBIT Margin (%) | 17.86 | 18.78 | 18.98 | 17.34 | 12.49 |
| PBT Margin (%) | 17.68 | 18.63 | 18.78 | 17.13 | 10.99 |
| Net Profit Margin (%) | 13.00 | 14.30 | 13.82 | 13.05 | 8.44 |
| NP After MI And SOA Margin (%) | 12.99 | 14.30 | 13.82 | 13.05 | 8.44 |
| Return on Networth / Equity (%) | 15.13 | 21.08 | 21.97 | 22.40 | 16.75 |
| Return on Capital Employeed (%) | 20.22 | 27.07 | 29.26 | 28.84 | 23.92 |
| Return On Assets (%) | 11.15 | 14.90 | 14.07 | 12.93 | 9.71 |
| Asset Turnover Ratio (%) | 0.85 | 1.10 | 1.08 | 1.11 | 1.23 |
| Current Ratio (X) | 3.34 | 2.99 | 2.47 | 2.14 | 2.08 |
| Quick Ratio (X) | 2.58 | 2.03 | 1.55 | 1.44 | 1.38 |
| Inventory Turnover Ratio (X) | 1.88 | 2.03 | 2.18 | 2.33 | 2.03 |
| Dividend Payout Ratio (NP) (%) | 83.74 | 9.93 | 9.42 | 7.95 | 10.52 |
| Dividend Payout Ratio (CP) (%) | 71.68 | 9.00 | 8.52 | 7.00 | 8.76 |
| Earning Retention Ratio (%) | 16.26 | 90.07 | 90.58 | 92.05 | 89.48 |
| Cash Earning Retention Ratio (%) | 28.32 | 91.00 | 91.48 | 93.00 | 91.24 |
| Interest Coverage Ratio (X) | 111.66 | 131.90 | 101.62 | 90.99 | 62.38 |
| Interest Coverage Ratio (Post Tax) (X) | 73.40 | 94.11 | 69.68 | 63.18 | 43.73 |
| Enterprise Value (Cr.) | 17160.49 | 20923.34 | 22359.99 | 14273.20 | 9063.32 |
| EV / Net Operating Revenue (X) | 6.03 | 5.96 | 7.30 | 5.40 | 3.74 |
| EV / EBITDA (X) | 30.09 | 29.41 | 35.68 | 28.24 | 26.36 |
| MarketCap / Net Operating Revenue (X) | 6.10 | 6.05 | 7.32 | 5.49 | 3.78 |
| Retention Ratios (%) | 16.25 | 90.06 | 90.57 | 92.04 | 89.47 |
| Price / BV (X) | 7.10 | 8.91 | 11.64 | 9.42 | 7.50 |
| Price / Net Operating Revenue (X) | 6.10 | 6.05 | 7.32 | 5.49 | 3.78 |
| EarningsYield | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 |
After reviewing the key financial ratios for Sumitomo Chemical India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 7.40. This value is within the healthy range. It has decreased from 10.06 (Mar 23) to 7.40, marking a decrease of 2.66.
- For Diluted EPS (Rs.), as of Mar 24, the value is 7.40. This value is within the healthy range. It has decreased from 10.06 (Mar 23) to 7.40, marking a decrease of 2.66.
- For Cash EPS (Rs.), as of Mar 24, the value is 8.65. This value is within the healthy range. It has decreased from 11.10 (Mar 23) to 8.65, marking a decrease of 2.45.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 48.97. It has increased from 47.72 (Mar 23) to 48.97, marking an increase of 1.25.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 48.97. It has increased from 47.72 (Mar 23) to 48.97, marking an increase of 1.25.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 56.98. It has decreased from 70.34 (Mar 23) to 56.98, marking a decrease of 13.36.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 11.42. This value is within the healthy range. It has decreased from 14.25 (Mar 23) to 11.42, marking a decrease of 2.83.
- For PBIT / Share (Rs.), as of Mar 24, the value is 10.18. This value is within the healthy range. It has decreased from 13.21 (Mar 23) to 10.18, marking a decrease of 3.03.
- For PBT / Share (Rs.), as of Mar 24, the value is 10.08. This value is within the healthy range. It has decreased from 13.11 (Mar 23) to 10.08, marking a decrease of 3.03.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 7.41. This value is within the healthy range. It has decreased from 10.06 (Mar 23) to 7.41, marking a decrease of 2.65.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 7.40. This value is within the healthy range. It has decreased from 10.06 (Mar 23) to 7.40, marking a decrease of 2.66.
- For PBDIT Margin (%), as of Mar 24, the value is 20.05. This value is within the healthy range. It has decreased from 20.26 (Mar 23) to 20.05, marking a decrease of 0.21.
- For PBIT Margin (%), as of Mar 24, the value is 17.86. This value is within the healthy range. It has decreased from 18.78 (Mar 23) to 17.86, marking a decrease of 0.92.
- For PBT Margin (%), as of Mar 24, the value is 17.68. This value is within the healthy range. It has decreased from 18.63 (Mar 23) to 17.68, marking a decrease of 0.95.
- For Net Profit Margin (%), as of Mar 24, the value is 13.00. This value exceeds the healthy maximum of 10. It has decreased from 14.30 (Mar 23) to 13.00, marking a decrease of 1.30.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 12.99. This value is within the healthy range. It has decreased from 14.30 (Mar 23) to 12.99, marking a decrease of 1.31.
- For Return on Networth / Equity (%), as of Mar 24, the value is 15.13. This value is within the healthy range. It has decreased from 21.08 (Mar 23) to 15.13, marking a decrease of 5.95.
- For Return on Capital Employeed (%), as of Mar 24, the value is 20.22. This value is within the healthy range. It has decreased from 27.07 (Mar 23) to 20.22, marking a decrease of 6.85.
- For Return On Assets (%), as of Mar 24, the value is 11.15. This value is within the healthy range. It has decreased from 14.90 (Mar 23) to 11.15, marking a decrease of 3.75.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.85. It has decreased from 1.10 (Mar 23) to 0.85, marking a decrease of 0.25.
- For Current Ratio (X), as of Mar 24, the value is 3.34. This value exceeds the healthy maximum of 3. It has increased from 2.99 (Mar 23) to 3.34, marking an increase of 0.35.
- For Quick Ratio (X), as of Mar 24, the value is 2.58. This value exceeds the healthy maximum of 2. It has increased from 2.03 (Mar 23) to 2.58, marking an increase of 0.55.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.88. This value is below the healthy minimum of 4. It has decreased from 2.03 (Mar 23) to 1.88, marking a decrease of 0.15.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 83.74. This value exceeds the healthy maximum of 50. It has increased from 9.93 (Mar 23) to 83.74, marking an increase of 73.81.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 71.68. This value exceeds the healthy maximum of 50. It has increased from 9.00 (Mar 23) to 71.68, marking an increase of 62.68.
- For Earning Retention Ratio (%), as of Mar 24, the value is 16.26. This value is below the healthy minimum of 40. It has decreased from 90.07 (Mar 23) to 16.26, marking a decrease of 73.81.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 28.32. This value is below the healthy minimum of 40. It has decreased from 91.00 (Mar 23) to 28.32, marking a decrease of 62.68.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 111.66. This value is within the healthy range. It has decreased from 131.90 (Mar 23) to 111.66, marking a decrease of 20.24.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 73.40. This value is within the healthy range. It has decreased from 94.11 (Mar 23) to 73.40, marking a decrease of 20.71.
- For Enterprise Value (Cr.), as of Mar 24, the value is 17,160.49. It has decreased from 20,923.34 (Mar 23) to 17,160.49, marking a decrease of 3,762.85.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 6.03. This value exceeds the healthy maximum of 3. It has increased from 5.96 (Mar 23) to 6.03, marking an increase of 0.07.
- For EV / EBITDA (X), as of Mar 24, the value is 30.09. This value exceeds the healthy maximum of 15. It has increased from 29.41 (Mar 23) to 30.09, marking an increase of 0.68.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 6.10. This value exceeds the healthy maximum of 3. It has increased from 6.05 (Mar 23) to 6.10, marking an increase of 0.05.
- For Retention Ratios (%), as of Mar 24, the value is 16.25. This value is below the healthy minimum of 30. It has decreased from 90.06 (Mar 23) to 16.25, marking a decrease of 73.81.
- For Price / BV (X), as of Mar 24, the value is 7.10. This value exceeds the healthy maximum of 3. It has decreased from 8.91 (Mar 23) to 7.10, marking a decrease of 1.81.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 6.10. This value exceeds the healthy maximum of 3. It has increased from 6.05 (Mar 23) to 6.10, marking an increase of 0.05.
- For EarningsYield, as of Mar 24, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Sumitomo Chemical India Ltd:
- Net Profit Margin: 13%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 20.22% (Industry Average ROCE: 15.26%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 15.13% (Industry Average ROE: 19.94%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 73.4
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.58
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 49.2 (Industry average Stock P/E: 36.69)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 13%
About the Company - Qualitative Analysis
Sumitomo Chemical India Ltd. is a Public Limited Listed company incorporated on 15/02/2000 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24110MH2000PLC124224 and registration number is 124224. Currently Company is involved in the business activities of Manufacture of pesticides and other agrochemical products. Company's Total Operating Revenue is Rs. 3090.37 Cr. and Equity Capital is Rs. 499.15 Cr. for the Year ended 31/03/2025.
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Agro Chemicals/Pesticides | Bldg. No. 1, Ground Floor, Shant Manor Co-op Housing Society Ltd., Mumbai Maharashtra 400101 | investor.relations@sumichem.co.in http://www.sumichem.co.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Mukul G Asher | Chairman |
| Mr. Chetan Shah | Managing Director |
| Mr. Sushil Marfatia | Executive Director |
| Dr. Suresh Ramachandran | Whole Time Director |
| Mr. B V Bhargava | Independent Director |
| Mrs. Preeti Mehta | Independent Director |
| Mr. Ninad D Gupte | Non Exe.Non Ind.Director |
| Mr. Masanori Uzawa | Non Exe.Non Ind.Director |
| Mr. Tadashi Katayama | Non Exe.Non Ind.Director |
FAQ
What is the intrinsic value of Sumitomo Chemical India Ltd?
Sumitomo Chemical India Ltd's intrinsic value (as of 13 June 2025) is ₹429.95 — 13.14% lower the current market price of 495.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 24,685 Cr. market cap, FY2025-2026 high/low of ₹628/446, reserves of 2,397 Cr, and liabilities of 3,930 Cr.
What is the Market Cap of Sumitomo Chemical India Ltd?
The Market Cap of Sumitomo Chemical India Ltd is 24,685 Cr..
What is the current Stock Price of Sumitomo Chemical India Ltd as on 13 June 2025?
The current stock price of Sumitomo Chemical India Ltd as on 13 June 2025 is 495.
What is the High / Low of Sumitomo Chemical India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Sumitomo Chemical India Ltd stocks is ₹628/446.
What is the Stock P/E of Sumitomo Chemical India Ltd?
The Stock P/E of Sumitomo Chemical India Ltd is 49.2.
What is the Book Value of Sumitomo Chemical India Ltd?
The Book Value of Sumitomo Chemical India Ltd is 58.0.
What is the Dividend Yield of Sumitomo Chemical India Ltd?
The Dividend Yield of Sumitomo Chemical India Ltd is 0.18 %.
What is the ROCE of Sumitomo Chemical India Ltd?
The ROCE of Sumitomo Chemical India Ltd is 25.1 %.
What is the ROE of Sumitomo Chemical India Ltd?
The ROE of Sumitomo Chemical India Ltd is 18.8 %.
What is the Face Value of Sumitomo Chemical India Ltd?
The Face Value of Sumitomo Chemical India Ltd is 10.0.